Registry Search

8,240 Clinical Drug Overviews

Medication	Therapeutic Class	Generic Mapping	Safety
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE	safe
EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE	safe
EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE	safe
EMTRICITABINE; RILPIVIRINE; TENOFOVIR ALAFENAMIDE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EMTRICITABINE; RILPIVIRINE; TENOFOVIR ALAFENAMIDE	safe
EMTRICITABINE; TENOFOVIR ALAFENAMIDE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EMTRICITABINE; TENOFOVIR ALAFENAMIDE	safe
EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE Other nephrotoxic drugs increase risk of renal impairment Can cause renal impairment and decreased bone mineral density.	NRTI	EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE	safe
EMTRIVA Comprehensive clinical and safety monograph for EMTRIVA (EMTRIVA).	Antiretroviral, NRTI	EMTRIVA	caution
EMVERM Comprehensive clinical and safety monograph for EMVERM (EMVERM).	Anthelmintic	EMVERM	caution
EMZAHH Comprehensive clinical and safety monograph for EMZAHH (EMZAHH).	Antiretroviral, Integrase Inhibitor + NRTIs	EMZAHH	caution
ENABLEX Comprehensive clinical and safety monograph for ENABLEX (ENABLEX).	Antimuscarinic	ENABLEX	caution
ENALAPRIL MALEATE NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.	ACE Inhibitor	ENALAPRIL MALEATE	avoid
ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE Other antihypertensive drugs can have additive effects Lithium levels may be increased Can cause hypokalemia and hyponatremia.	Thiazide Diuretic	ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE	safe
ENALAPRILAT NSAIDs may diminish the antihypertensive effect Lithium levels may be increased Risk of angioedema can occur at any time discontinue immediately.	ACE Inhibitor	ENALAPRILAT	avoid
ENBREL Comprehensive clinical and safety monograph for ENBREL (ENBREL).	TNF-alpha Inhibitor	ENBREL	caution
ENBUMYST Comprehensive clinical and safety monograph for ENBUMYST (ENBUMYST).	Mucolytic	ENBUMYST	caution
ENDARI Comprehensive clinical and safety monograph for ENDARI (ENDARI).	Sickle Cell Agent	ENDARI	caution
ENDEP Comprehensive clinical and safety monograph for ENDEP (ENDEP).	Tricyclic Antidepressant	ENDEP	caution
ENDOMETRIN Comprehensive clinical and safety monograph for ENDOMETRIN (ENDOMETRIN).	Progestin	ENDOMETRIN	caution
ENDURON Comprehensive clinical and safety monograph for ENDURON (ENDURON).	Thiazide Diuretic	ENDURON	caution
ENDURONYL Comprehensive clinical and safety monograph for ENDURONYL (ENDURONYL).	Thiazide Diuretic + Rauwolfia Alkaloid	ENDURONYL	caution
ENDURONYL FORTE Comprehensive clinical and safety monograph for ENDURONYL FORTE (ENDURONYL FORTE).	Thiazide Diuretic + Rauwolfia Alkaloid	ENDURONYL FORTE	caution
ENFLONSIA Comprehensive clinical and safety monograph for ENFLONSIA (ENFLONSIA).	Inhalational Anesthetic	ENFLONSIA	caution
ENFLURANE Comprehensive clinical and safety monograph for ENFLURANE (ENFLURANE).	Inhalational Anesthetic	ENFLURANE	caution
ENHERTU Comprehensive clinical and safety monograph for ENHERTU (ENHERTU).	Antineoplastic Agent	ENHERTU	caution
ENILLORING Comprehensive clinical and safety monograph for ENILLORING (ENILLORING).	Nonsteroidal Anti-inflammatory Drug	ENILLORING	caution
ENJAYMO Comprehensive clinical and safety monograph for ENJAYMO (ENJAYMO).	Complement Inhibitor	ENJAYMO	caution
ENJUVIA Comprehensive clinical and safety monograph for ENJUVIA (ENJUVIA).	Estrogen Replacement Therapy	ENJUVIA	caution
ENLON Comprehensive clinical and safety monograph for ENLON (ENLON).	Cholinesterase Inhibitor	ENLON	caution
ENLON-PLUS Comprehensive clinical and safety monograph for ENLON-PLUS (ENLON-PLUS).	Cholinesterase Inhibitor Combination	ENLON-PLUS	caution
ENOBY Comprehensive clinical and safety monograph for ENOBY (ENOBY).	Selective Androgen Receptor Modulator	ENOBY	caution
ENOVID Comprehensive clinical and safety monograph for ENOVID (ENOVID).	Oral Contraceptive	ENOVID	caution
ENOVID-E Comprehensive clinical and safety monograph for ENOVID-E (ENOVID-E).	Oral Contraceptive	ENOVID-E	caution
ENOVID-E 21 Comprehensive clinical and safety monograph for ENOVID-E 21 (ENOVID-E 21).	Oral Contraceptive	ENOVID-E 21	caution
Enoxaparin Standard of care for VTE prevention and treatment in pregnancy. Does not cross the placenta due to its large molecular weight. No teratogenicity. Requires dose adjustment in pregnancy (weight-based; anti-Xa monitoring in some cases). Renal function monitoring recommended. Switch to unfractionated heparin (UFH) at 36–37 weeks to allow neuraxial anesthesia planning.	Low Molecular Weight Heparin		safe
ENOXAPARIN SODIUM Other drugs that affect hemostasis increase bleeding risk Can cause spinal or epidural hematoma leading to paralysis with neuraxial anesthesia.	Low Molecular Weight Heparin	ENOXAPARIN SODIUM	safe
ENOXAPARIN SODIUM (PRESERVATIVE FREE) Other drugs that affect hemostasis increase bleeding risk Can cause spinal or epidural hematoma leading to paralysis with neuraxial anesthesia.	Low Molecular Weight Heparin	ENOXAPARIN SODIUM (PRESERVATIVE FREE)	safe
ENPRESSE-21 Comprehensive clinical and safety monograph for ENPRESSE-21 (ENPRESSE-21).	Oral Contraceptive	ENPRESSE-21	caution
ENPRESSE-28 Comprehensive clinical and safety monograph for ENPRESSE-28 (ENPRESSE-28).	Oral Contraceptive	ENPRESSE-28	caution
ENSACOVE Comprehensive clinical and safety monograph for ENSACOVE (ENSACOVE).	Phosphodiesterase Inhibitor	ENSACOVE	caution
ENSKYCE Comprehensive clinical and safety monograph for ENSKYCE (ENSKYCE).	Oral Contraceptive	ENSKYCE	caution
ENSPRYNG Comprehensive clinical and safety monograph for ENSPRYNG (ENSPRYNG).	Interleukin-6 Receptor Antagonist	ENSPRYNG	caution
ENSTILAR Comprehensive clinical and safety monograph for ENSTILAR (ENSTILAR).	Topical Corticosteroid and Vitamin D Analog	ENSTILAR	caution
ENTACAPONE Nonselective MAOIs are contraindicated Can cause diarrhea and urine discoloration.	COMT Inhibitor	ENTACAPONE	safe
ENTADFI Comprehensive clinical and safety monograph for ENTADFI (ENTADFI).	5-Alpha Reductase Inhibitor and PDE5 Inhibitor	ENTADFI	caution
ENTECAVIR Drugs that reduce renal function may increase levels Severe acute exacerbations of hepatitis B have been reported upon discontinuation.	Nucleoside Reverse Transcriptase Inhibitor	ENTECAVIR	safe
ENTEREG Comprehensive clinical and safety monograph for ENTEREG (ENTEREG).	Peripheral Opioid Antagonist	ENTEREG	caution
ENTERO VU 24% Comprehensive clinical and safety monograph for ENTERO VU 24% (ENTERO VU 24%).	Diagnostic Imaging Contrast Agent	ENTERO VU 24%	caution
ENTOCORT EC Comprehensive clinical and safety monograph for ENTOCORT EC (ENTOCORT EC).	Corticosteroid	ENTOCORT EC	caution
ENTRESTO Comprehensive clinical and safety monograph for ENTRESTO (ENTRESTO).	Angiotensin Receptor-Neprilysin Inhibitor (ARNI)	ENTRESTO	caution
ENTRESTO SPRINKLE Comprehensive clinical and safety monograph for ENTRESTO SPRINKLE (ENTRESTO SPRINKLE).	Angiotensin Receptor-Neprilysin Inhibitor (ARNI)	ENTRESTO SPRINKLE	caution

Showing 2451 - 2500 of 8245

Previous Next